Metformin Attenuates Osteoporosis in Diabetic Patients with Carcinoma in Situ: A Nationwide, Retrospective, Matched-Cohort Study in Taiwan

Metformin Attenuates Osteoporosis in Diabetic Patients with Carcinoma in Situ: A Nationwide, Retrospective, Matched-Cohort Study in Taiwan

Patients with diabetes are at increased risk of cancer development and osteoporosis. Metformin is an effective agent for diabetes management. Epidemiological studies have identified an association between metformin use and cancer prevention. This article outlines the potential for metformin to atten...

Full description

Bibliographic Details
Main Authors: Chieh-Hua Lu, Chi-Hsiang Chung, Feng-Chih Kuo, Kuan-Chan Chen, Chia-Hao Chang, Chih-Chun Kuo, Chien-Hsing Lee, Sheng-Chiang Su, Jhih-Syuan Liu, Fu-Huang Lin, Chang-Huei Tsao, Po-Shiuan Hsieh, Yi-Jen Hung, Chang-Hsun Hsieh, Wu-Chien Chien
Format: Article
Language:English
Published: MDPI AG 2020-09-01
Series:Journal of Clinical Medicine
Subjects:
osteoporosis
diabetes
metformin
carcinoma in situ
National Health Insurance Research Database
Online Access:https://www.mdpi.com/2077-0383/9/9/2839

Internet

https://www.mdpi.com/2077-0383/9/9/2839

Similar Items